Search
Search Funnelback University
- Refined by:
- Date: Past 6 months
Your query has been expanded to TALK:PC53 20 |u:www.enterprize.cam.ac.uk. Search for TALK:PC53 20 |u:www.enterprise.cam.ac.uk instead.
1 -
10 of
46
search results for TALK:PC53 20 |u:www.enterprise.cam.ac.uk or TALK:PC53 20 |u:www.enterprize.cam.ac.uk
where 0
match all words and 46
match some words.
Results that match 1 of 2 words
-
Latest news, case studies and blogs – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/latest-news/
11 Apr 2024:
Catch up on our latest developments to see how we're creating impact for the benefit of society, the economy and the University.
-
Ideas to Reality 2022 – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/our-events/ideas-to-reality-2022/
4 Mar 2024:
Ideas to Reality 2022 is a showcase event and celebration of world-changing research, ideas and expertise from the University of Cambridge, commercialised with the support of Cambridge Enterprise.
-
Innovative aquaculture system turns waste wood into nutritious…
https://www.enterprise.cam.ac.uk/news/naked-clams/
24 Jan 2024:
20 November 2023. Innovative aquaculture system turns waste wood into nutritious seafood.
-
Genius of the place: Cambridge’s Creative Promise – Cambridge…
https://www.enterprise.cam.ac.uk/genius-of-the-place-cambridges-creative-promise/
20 Jun 2024:
20 June 2024. Genius of the place: Cambridge’s Creative Promise. Share:.
-
Dr Ananay Aguilar – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/team/dr-ananay-aguilar/
1 Feb 2024:
Ananay oversees the activities of TenU, an international collaboration of leading tech transfer offices created to share effective practices in research commercialisation...
-
LGR5 monoclonal antibody for cancer immunotherapy – Cambridge…
https://www.enterprise.cam.ac.uk/opportunities/lgr5-de-7580-20/
4 Jan 2024:
A first-in-class humanised monoclonal antibody against LGR5 validated as a platform for ADC, BiTE and CAR-T therapies. Collaboration/licence
-
Fast track equity option – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/fast-track-equity-option/
24 Jun 2024:
20% equity for patented Therapeutic Technologies. Under the University IP Policy, University of Cambridge founders do not require a licence to non-patented Other Technologies in certain situations. ... The fast-track model has four streams, ranging from
-
Ventures – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/about/our-team/ventures/20 Mar 2024: She is the author of over 20 peer reviewed journal articles and over 20 patents. ... She has more than 20 years experience advising on corporate legal matters especially for investments into spin outs of the University in the technology and life sciences -
Cambridge Enterprise Ventures – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-external-organisations/cambridge-enterprise-ventures/
25 Jun 2024:
Over 20 years of investing at the University of Cambridge has seen a host of successes including XO1, BlueGnome, Cambridge CMOS Sensors, Centessa, Gyroscope, Solexa, Quethera and VocalIQ.
-
Harnessing the power of innovation – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/harnessing-the-power-of-innovation/
6 Jun 2024:
The change that has taken place over the last 20 or 30 years is extraordinary – and welcome. ... What one piece of advice would you give your 20-year old self given what you’ve learnt in your life or career?
11 Apr 2024:
Catch up on our latest developments to see how we're creating impact for the benefit of society, the economy and the University.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.